Skip to main content
. 2022 Dec 29;11(1):80. doi: 10.3390/biomedicines11010080

Table 2.

Results of univariate meta-regression analyses.

Coef (B) 95% CI p
Lower Limit Upper Limit
Augmentation Strategy −0.02 −0.88 0.46 0.54
Sessions per day 0.49 −0.18 1.18 0.15
Session duration −0.27 −0.09 0.41 0.43
Number of weeks −0.05 −0.16 0.48 0.27
Session total −0.03 −0.08 0.01 0.18

Note: Meta-regressions were performed using one variable per time due to the relatively low sample size included in this meta-analysis. Statistical significance was indicated by p ≤ 0.05. Therefore, no variable was found to be statistically significant. Augmentation strategy: tDCS combined with concurrently commenced other interventions (i.e., pharmacotherapy). Abbreviation: CI—confidence interval.